J. Exp. Med., Volume 188, Number 3, August 3, 1998 589-596

Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

By Katia Boggio,^* Giordano Nicoletti,^§ Emma Di Carlo, Federica Cavallo,^* Lorena Landuzzi,^§ Cecilia Melani,^¶ Mirella Giovarelli,^* Ilaria Rossi, Patrizia Nanni, Carla De Giovanni, Page Bouchard,^** Stanley Wolf,^** Andrea Modesti, Piero Musiani, Pier Luigi Lollini, Mario P. Colombo,^¶ and Guido Forni^*

From the ^* Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy; the  Institute for Cancer Research, University of Bologna, 40126 Bologna, Italy; the ^§ IST Biotechnology Satellite Unit of Bologna, 40126 Bologna, Italy; the  Department of Oncology and Neuroscience, G. d'Annunzio University, 66013 Chieti, Italy; the ^¶ National Tumor Institute, 20133 Milan, Italy; and the ^** Genetics Institute, Cambridge, Massachusetts 02140

The ability of interleukin (IL)-12 to prevent tumors when administered to individuals with a genetic risk of cancer was studied in two lines of transgenic mice expressing rat HER-2/neu oncogene in the mammary gland. Female BALB/c (H-2^d) mice carrying the activated HER-2/ neu oncogene show no morphological abnormalities of the mammary gland until 3 wk of age. They then progress through atypical hyperplasia to in situ lobular carcinoma and at 33 wk of age all 10 mammary glands display invasive carcinomas. Adult FVB mice (H-2^q) carrying the HER-2/neu protooncogene develop mammary carcinomas with a longer latency (38-49 wk) and a lower multiplicity (mean of 2.6 tumors/mice). Treatment with IL-12 (5 daily intraperitoneal injections, 1 wk on, 3 wk off; the first course with 50 ng IL-12/day, the second with 100 ng IL-12/day) begun at 2 wk of age in BALB/c mice and at 21 wk of age in FVB mice markedly delayed tumor onset and reduced tumor multiplicity. Analogous results were obtained in immunocompetent and permanently CD8⁺ T lymphocyte-depleted mice. In both transgenic lines, tumor inhibition was associated with mammary infiltration of reactive cells, production of cytokines and inducible nitric oxide synthase, and reduction in microvessel number, in combination with a high degree of hemorrhagic necrosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wei, H., Wang, S., Zhang, D., Hou, S., Qian, W., Li, B., Guo, H., Kou, G., He, J., Wang, H., Guo, Y. (2009). Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice. Clin. Cancer Res. 15: 4612-4621 [Abstract] [Full Text]  
• Jacob, J. B., Kong, Y.-c. M., Nalbantoglu, I., Snower, D. P., Wei, W.-Z. (2009). Tumor Regression following DNA Vaccination and Regulatory T Cell Depletion in neu Transgenic Mice Leads to an Increased Risk for Autoimmunity. J. Immunol. 182: 5873-5881 [Abstract] [Full Text]  
• Norian, L. A., Rodriguez, P. C., O'Mara, L. A., Zabaleta, J., Ochoa, A. C., Cella, M., Allen, P. M. (2009). Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via L-Arginine Metabolism. Cancer Res. 69: 3086-3094 [Abstract] [Full Text]  
• Assudani, D., Cho, H.-I., DeVito, N., Bradley, N., Celis, E. (2008). In vivo Expansion, Persistence, and Function of Peptide Vaccine-Induced CD8 T Cells Occur Independently of CD4 T Cells. Cancer Res. 68: 9892-9899 [Abstract] [Full Text]  
• Sloots, A., Mastini, C., Rohrbach, F., Weth, R., Curcio, C., Burkhardt, U., Jager, E., Forni, G., Cavallo, F., Wels, W. S. (2008). DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma. Clin. Cancer Res. 14: 6933-6943 [Abstract] [Full Text]  
• Ciraolo, E., Iezzi, M., Marone, R., Marengo, S., Curcio, C., Costa, C., Azzolino, O., Gonella, C., Rubinetto, C., Wu, H., Dastru, W., Martin, E. L., Silengo, L., Altruda, F., Turco, E., Lanzetti, L., Musiani, P., Ruckle, T., Rommel, C., Backer, J. M., Forni, G., Wymann, M. P., Hirsch, E. (2008). Phosphoinositide 3-Kinase p110{beta} Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development. Sci Signal 1: ra3-ra3 [Abstract] [Full Text]  
• Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., Colombo, M. P. (2007). Amino-Biphosphonate Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma. Cancer Res. 67: 11438-11446 [Abstract] [Full Text]  
• Nanni, P., Nicoletti, G., Palladini, A., Croci, S., Murgo, A., Antognoli, A., Landuzzi, L., Fabbi, M., Ferrini, S., Musiani, P., Iezzi, M., De Giovanni, C., Lollini, P.-L. (2007). Antimetastatic Activity of a Preventive Cancer Vaccine. Cancer Res. 67: 11037-11044 [Abstract] [Full Text]  
• Spadaro, M., Curcio, C., Varadhachary, A., Cavallo, F., Engelmayer, J., Blezinger, P., Pericle, F., Forni, G. (2007). Requirement for IFN-{gamma}, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors. Cancer Res. 67: 6425-6432 [Abstract] [Full Text]  
• Allen, S. D., Garrett, J. T., Rawale, S. V., Jones, A. L., Phillips, G., Forni, G., Morris, J. C., Oshima, R. G., Kaumaya, P. T. P. (2007). Peptide Vaccines of the HER-2/neu Dimerization Loop Are Effective in Inhibiting Mammary Tumor Growth In Vivo. J. Immunol. 179: 472-482 [Abstract] [Full Text]  
• Street, S. E.A., Zerafa, N., Iezzi, M., Westwood, J. A., Stagg, J., Musiani, P., Smyth, M. J. (2007). Host Perforin Reduces Tumor Number but Does Not Increase Survival in Oncogene-Driven Mammary Adenocarcinoma. Cancer Res. 67: 5454-5460 [Abstract] [Full Text]  
• Garrett, J. T., Rawale, S., Allen, S. D., Phillips, G., Forni, G., Morris, J. C., Kaumaya, P. T. P. (2007). Novel Engineered Trastuzumab Conformational Epitopes Demonstrate In Vitro and In Vivo Antitumor Properties against HER-2/neu. J. Immunol. 178: 7120-7131 [Abstract] [Full Text]  
• Nava-Parada, P., Forni, G., Knutson, K. L., Pease, L. R., Celis, E. (2007). Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors. Cancer Res. 67: 1326-1334 [Abstract] [Full Text]  
• Rolla, S., Nicolo, C., Malinarich, S., Orsini, M., Forni, G., Cavallo, F., Ria, F. (2006). Distinct and Non-Overlapping T Cell Receptor Repertoires Expanded by DNA Vaccination in Wild-Type and HER-2 Transgenic BALB/c Mice. J. Immunol. 177: 7626-7633 [Abstract] [Full Text]  
• Chen, X.-c., Wang, R., Zhao, X., Wei, Y.-q., Hu, M., Wang, Y.-s., Zhang, X.-w., Zhang, R., Zhang, L., Yao, B., Wang, L., Jia, Y.-q., Zeng, T.-t., Yang, J.-l., Tian, L., Kan, B., Lin, X.-j., Lei, S., Deng, H.-x., Wen, Y.-j., Mao, Y.-q., Li, J. (2006). Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs. Carcinogenesis 27: 2434-2441 [Abstract] [Full Text]  
• Chiodoni, C., Iezzi, M., Guiducci, C., Sangaletti, S., Alessandrini, I., Ratti, C., Tiboni, F., Musiani, P., Granger, D. N., Colombo, M. P. (2006). Triggering CD40 on endothelial cells contributes to tumor growth. JEM 203: 2441-2450 [Abstract] [Full Text]  
• Nelson, D., Ganss, R. (2006). Tumor growth or regression: powered by inflammation. J. Leukoc. Biol. 80: 685-690 [Abstract] [Full Text]  
• Ambrosino, E., Spadaro, M., Iezzi, M., Curcio, C., Forni, G., Musiani, P., Wei, W.-Z., Cavallo, F. (2006). Immunosurveillance of erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.. Cancer Res. 66: 7734-7740 [Abstract] [Full Text]  
• Pannellini, T., Spadaro, M., Di Carlo, E., Ambrosino, E., Iezzi, M., Amici, A., Lollini, P. L., Forni, G., Cavallo, F., Musiani, P. (2006). Timely DNA Vaccine Combined with Systemic IL-12 Prevents Parotid Carcinomas before a Dominant-Negative p53 Makes Their Growth Independent of HER-2/neu Expression.. J. Immunol. 176: 7695-7703 [Abstract] [Full Text]  
• Holmgren, L., Ambrosino, E., Birot, O., Tullus, C., Veitonmaki, N., Levchenko, T., Carlson, L.-M., Musiani, P., Iezzi, M., Curcio, C., Forni, G., Cavallo, F., Kiessling, R. (2006). A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc. Natl. Acad. Sci. USA 103: 9208-9213 [Abstract] [Full Text]  
• Cabodi, S., Tinnirello, A., Di Stefano, P., Bisaro, B., Ambrosino, E., Castellano, I., Sapino, A., Arisio, R., Cavallo, F., Forni, G., Glukhova, M., Silengo, L., Altruda, F., Turco, E., Tarone, G., Defilippi, P. (2006). p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene-Dependent Breast Tumorigenesis.. Cancer Res. 66: 4672-4680 [Abstract] [Full Text]  
• Valzasina, B., Piconese, S., Guiducci, C., Colombo, M. P. (2006). Tumor-Induced Expansion of Regulatory T Cells by Conversion of CD4+CD25- Lymphocytes Is Thymus and Proliferation Independent.. Cancer Res. 66: 4488-4495 [Abstract] [Full Text]  
• Wei, W.-Z., Jacob, J. B., Zielinski, J. F., Flynn, J. C., Shim, K. D., Alsharabi, G., Giraldo, A. A., Kong, Y.-c. M. (2005). Concurrent Induction of Antitumor Immunity and Autoimmune Thyroiditis in CD4+CD25+ Regulatory T Cell-Depleted Mice. Cancer Res. 65: 8471-8478 [Abstract] [Full Text]  
• Tegerstedt, K., Lindencrona, J. A., Curcio, C., Andreasson, K., Tullus, C., Forni, G., Dalianis, T., Kiessling, R., Ramqvist, T. (2005). A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/neu-Expressing Tumors. Cancer Res. 65: 5953-5957 [Abstract] [Full Text]  
• O'Mara, L. A., Norian, L. A., Kreamalmeyer, D., White, J. M., Allen, P. M. (2005). T Cell-Mediated Delay of Spontaneous Mammary Tumor Onset: Increased Efficacy with In Vivo versus In Vitro Activation. J. Immunol. 174: 4662-4669 [Abstract] [Full Text]  
• Park, J. M., Terabe, M., Sakai, Y., Munasinghe, J., Forni, G., Morris, J. C., Berzofsky, J. A. (2005). Early Role of CD4+ Th1 Cells and Antibodies in HER-2 Adenovirus Vaccine Protection against Autochthonous Mammary Carcinomas. J. Immunol. 174: 4228-4236 [Abstract] [Full Text]  
• Astolfi, A., Landuzzi, L., Nicoletti, G., De Giovanni, C., Croci, S., Palladini, A., Ferrini, S., Iezzi, M., Musiani, P., Cavallo, F., Forni, G., Nanni, P., Lollini, P.-L. (2005). Gene Expression Analysis of Immune-Mediated Arrest of Tumorigenesis in a Transgenic Mouse Model of HER-2/neu-Positive Basal-Like Mammary Carcinoma. Am. J. Pathol. 166: 1205-1216 [Abstract] [Full Text]  
• Spadaro, M., Ambrosino, E., Iezzi, M., Di Carlo, E., Sacchetti, P., Curcio, C., Amici, A., Wei, W.-Z., Musiani, P., Lollini, P.-L., Cavallo, F., Forni, G. (2005). Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity. Clin. Cancer Res. 11: 1941-1952 [Abstract] [Full Text]  
• Croci, S., Nicoletti, G., Landuzzi, L., De Giovanni, C., Astolfi, A., Marini, C., Di Carlo, E., Musiani, P., Forni, G., Nanni, P., Lollini, P.-L. (2004). Immunological Prevention of a Multigene Cancer Syndrome. Cancer Res. 64: 8428-8434 [Abstract] [Full Text]  
• Sakai, Y., Morrison, B. J., Burke, J. D., Park, J.-M., Terabe, M., Janik, J. E., Forni, G., Berzofsky, J. A., Morris, J. C. (2004). Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice. Cancer Res. 64: 8022-8028 [Abstract] [Full Text]  
• Takeuchi, N., Hiraoka, S.-i., Zhou, X.-Y., Nagafuku, M., Ono, S., Tsujimura, T., Nakazawa, M., Yura, Y., Hamaoka, T., Fujiwara, H. (2004). Anti-HER-2/neu Immune Responses Are Induced before the Development of Clinical Tumors but Declined following Tumorigenesis in HER-2/neu Transgenic Mice. Cancer Res. 64: 7588-7595 [Abstract] [Full Text]  
• Knostman, K. A. B., Cho, J.-Y., Ryu, K.-Y., Lin, X., McCubrey, J. A., Hla, T., Liu, C. H., Di Carlo, E., Keri, R., Zhang, M., Hwang, D. Y., Kisseberth, W. C., Capen, C. C., Jhiang, S. M. (2004). Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. J. Clin. Endocrinol. Metab. 89: 5196-5203 [Abstract] [Full Text]  
• Nanni, P., Landuzzi, L., Nicoletti, G., De Giovanni, C., Rossi, I., Croci, S., Astolfi, A., Iezzi, M., Di Carlo, E., Musiani, P., Forni, G., Lollini, P.-L. (2004). Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-{gamma} and B Cell Dependent. J. Immunol. 173: 2288-2296 [Abstract] [Full Text]  
• Liu, J., Xiang, Z., Ma, X. (2004). Role of IFN Regulatory Factor-1 and IL-12 in Immunological Resistance to Pathogenesis of N-Methyl-N-Nitrosourea-Induced T Lymphoma. J. Immunol. 173: 1184-1193 [Abstract] [Full Text]  
• De Giovanni, C., Nicoletti, G., Landuzzi, L., Astolfi, A., Croci, S., Comes, A., Ferrini, S., Meazza, R., Iezzi, M., Di Carlo, E., Musiani, P., Cavallo, F., Nanni, P., Lollini, P.-L. (2004). Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine. Cancer Res. 64: 4001-4009 [Abstract] [Full Text]  
• Quaglino, E., Iezzi, M., Mastini, C., Amici, A., Pericle, F., Di Carlo, E., Pupa, S. M., De Giovanni, C., Spadaro, M., Curcio, C., Lollini, P. L., Musiani, P., Forni, G., Cavallo, F. (2004). Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice. Cancer Res. 64: 2858-2864 [Abstract] [Full Text]  
• Piechocki, M. P., Ho, Y.-S., Pilon, S., Wei, W.-Z. (2003). Human ErbB-2 (Her-2) Transgenic Mice: A Model System for Testing Her-2 Based Vaccines. J. Immunol. 171: 5787-5794 [Abstract] [Full Text]  
• Sangaletti, S., Stoppacciaro, A., Guiducci, C., Torrisi, M. R., Colombo, M. P. (2003). Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma. JEM 198: 1475-1485 [Abstract] [Full Text]  
• Mitola, S., Strasly, M., Prato, M., Ghia, P., Bussolino, F. (2003). IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production. J. Immunol. 171: 3725-3733 [Abstract] [Full Text]  
• Melani, C., Chiodoni, C., Forni, G., Colombo, M. P. (2003). Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102: 2138-2145 [Abstract] [Full Text]  
• Hayakawa, Y., Rovero, S., Forni, G., Smyth, M. J. (2003). {alpha}-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis. Proc. Natl. Acad. Sci. USA 100: 9464-9469 [Abstract] [Full Text]  
• Lo, C.-H., Lee, S.-C., Wu, P.-Y., Pan, W.-Y., Su, J., Cheng, C.-W., Roffler, S. R., Chiang, B.-L., Lee, C.-N., Wu, C.-W., Tao, M.-H. (2003). Antitumor and Antimetastatic Activity of IL-23. J. Immunol. 171: 600-607 [Abstract] [Full Text]  
• Cappello, P., Triebel, F., Iezzi, M., Caorsi, C., Quaglino, E., Lollini, P.-L., Amici, A., Di Carlo, E., Musiani, P., Giovarelli, M., Forni, G. (2003). LAG-3 Enables DNA Vaccination to Persistently Prevent Mammary Carcinogenesis in HER-2/neu Transgenic BALB/c Mice. Cancer Res. 63: 2518-2525 [Abstract] [Full Text]  
• Nishioka, Y., Wen, H., Mitani, K., Robbins, P. D., Lotze, M. T., Sone, S., Tahara, H. (2003). Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide. J. Leukoc. Biol. 73: 621-629 [Abstract] [Full Text]  
• SFONDRINI, L., BESUSSO, D., RUMIO, C., RODOLFO, M., MENARD, S., BALSARI, A. (2002). Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA. FASEB J. 16: 1749-1754 [Abstract] [Full Text]  
• Ganss, R., Ryschich, E., Klar, E., Arnold, B., Hammerling, G. J. (2002). Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication. Cancer Res. 62: 1462-1470 [Abstract] [Full Text]  
• Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., Smyth, M. J. (2002). Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice. J. Immunol. 168: 1356-1361 [Abstract] [Full Text]  
• Nanni, P., Nicoletti, G., De Giovanni, C., Landuzzi, L., Di Carlo, E., Cavallo, F., Pupa, S. M., Rossi, I., Colombo, M. P., Ricci, C., Astolfi, A., Musiani, P., Forni, G., Lollini, P.-L. (2001). Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice. JEM 194: 1195-1206 [Abstract] [Full Text]  
• Soares, M. M., Mehta, V., Finn, O. J. (2001). Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection. J. Immunol. 166: 6555-6563 [Abstract] [Full Text]  
• Cifaldi, L., Quaglino, E., Di Carlo, E., Musiani, P., Spadaro, M., Lollini, P. L., Wolf, S., Boggio, K., Forni, G., Cavallo, F. (2001). A Light, Nontoxic Interleukin 12 Protocol Inhibits HER-2/neu Mammary Carcinogenesis in BALB/c Transgenic Mice with Established Hyperplasia. Cancer Res. 61: 2809-2812 [Abstract] [Full Text]  
• Cavallo, F., Quaglino, E., Cifaldi, L., Di Carlo, E., André, A., Bernabei, P., Musiani, P., Forni, G., Calogero, R. A. (2001). Interleukin 12-activated Lymphocytes Influence Tumor Genetic Programs. Cancer Res. 61: 3518-3523 [Abstract] [Full Text]  
• Strasly, M., Cavallo, F., Geuna, M., Mitola, S., Colombo, M. P., Forni, G., Bussolino, F. (2001). IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk. J. Immunol. 166: 3890-3899 [Abstract] [Full Text]  
• Roy, E. J., Gawlick, U., Orr, B. A., Rund, L. A., Webb, A. G., Kranz, D. M. (2000). IL-12 Treatment of Endogenously Arising Murine Brain Tumors. J. Immunol. 165: 7293-7299 [Abstract] [Full Text]  
• Rovero, S., Amici, A., Carlo, E. D., Bei, R., Nanni, P., Quaglino, E., Porcedda, P., Boggio, K., Smorlesi, A., Lollini, P.-L., Landuzzi, L., Colombo, M. P., Giovarelli, M., Musiani, P., Forni, G. (2000). DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice. J. Immunol. 165: 5133-5142 [Abstract] [Full Text]  
• Mortarini, R., Borri, A., Tragni, G., Bersani, I., Vegetti, C., Bajetta, E., Pilotti, S., Cerundolo, V., Anichini, A. (2000). Peripheral Burst of Tumor-specific Cytotoxic T Lymphocytes and Infiltration of Metastatic Lesions by Memory CD8+ T Cells in Melanoma Patients Receiving Interleukin 12. Cancer Res. 60: 3559-3568 [Abstract] [Full Text]  
• Sfondrini, L., Rodolfo, M., Singh, M., Colombo, M. P., Colnaghi, M. I., Ménard, S., Balsari, A. (2000). Cooperative Effects of Mycobacterium tuberculosis Ag38 Gene Transduction and Interleukin 12 in Vaccination against Spontaneous Tumor Development in Proto-neu Transgenic Mice. Cancer Res. 60: 3777-3781 [Abstract] [Full Text]  
• Forni, G., Lollini, P. L., Musiani, P., Colombo, M. P. (2000). Immunoprevention of Cancer: Is the Time Ripe?. Cancer Res. 60: 2571-2575 [Abstract] [Full Text]  
• Sacco, M. G., Caniatti, M., Catò, E. M., Frattini, A., Chiesa, G., Ceruti, R., Adorni, F., Zecca, L., Scanziani, E., Vezzoni, P. (2000). Liposome-delivered Angiostatin Strongly Inhibits Tumor Growth and Metastatization in a Transgenic Model of Spontaneous Breast Cancer. Cancer Res. 60: 2660-2665 [Abstract] [Full Text]  
• Ménard, S., Aiello, P., Tagliabue, E., Rumio, C., Lollini, P. L., Colnaghi, M. I., Balsari, A. (2000). Tamoxifen Chemoprevention of a Hormone-independent Tumor in the Proto-neu Transgenic Mice Model. Cancer Res. 60: 273-275 [Abstract] [Full Text]  
• Boggio, K., Di Carlo, E., Rovero, S., Cavallo, F., Quaglino, E., Lollini, P. L., Nanni, P., Nicoletti, G., Wolf, S., Musiani, P., Forni, G. (2000). Ability of Systemic Interleukin-12 to Hamper Progressive Stages of Mammary Carcinogenesis in HER2/neu Transgenic Mice. Cancer Res. 60: 359-364 [Abstract] [Full Text]  
• Cavallo, F., Carlo, E. D., Butera, M., Verrua, R., Colombo, M. P., Musiani, P., Forni, G. (1999). Immune Events Associated with the Cure of Established Tumors and Spontaneous Metastases by Local and Systemic Interleukin 12. Cancer Res. 59: 414-421 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS